{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:32:52Z","timestamp":1768534372460,"version":"3.49.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Myocardial infarction with non-obstructive coronary arteries (MINOCA) occurs in ~10% of all patients with acute myocardial infarction (AMI), with an over-representation amongst women. Remarkably, it is estimated that as many as 1 in 4 patients with MINOCA experience ongoing angina at 12 months despite having no flow-restricting stenoses in their epicardial arteries. This manuscript presents the rationale behind Randomized Evaluation of Beta Blocker and Angiotensin-converting enzyme inhibitors\/Angiotensin Receptor Blocker Treatment (ACEI\/ARB) for Post Infarct Angina in MINOCA patients\u2014The MINOCA BAT post infarct angina sub study.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This trial is a registry-based, randomized, parallel, open-label, multicenter trial with 2 \u00d7 2 factorial design. The primary aim is to determine whether oral beta blockade compared with no oral beta blockade, and ACEI\/ARB compared with no ACEI\/ARB, reduce post infarct angina in patients discharged after MINOCA without clinical signs of heart failure and with left ventricular ejection fraction \u226540%. A total of 664 patients will be randomized into four groups; (i) ACEI\/ARB with beta blocker, (ii) beta blocker only, (iii) ACEI\/ARB only, or (iv) neither ACEI\/ARB nor beta blocker and followed for 12 months.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The trial is currently recruiting in Australia and Sweden. Fifty six patients have been recruited thus far. Both sexes were equally distributed (52% women and 48% men) and the mean age was 56.3 \u00b1 9.9 years.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> It remains unclear whether conventional secondary preventive therapies are beneficial to MINOCA patients in regard to post infarct angina. Existing registry-based literature suggest cardioprotective agents are less likely to be used in MINOCA patients. Thus, results from this trial will provide insights for future treatment strategies and guidelines specific to MINOCA patients.<\/jats:p>","DOI":"10.3389\/fcvm.2021.717526","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T15:38:03Z","timestamp":1633880283000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Randomized Evaluation of Beta Blocker and ACE-Inhibitor\/Angiotensin Receptor Blocker Treatment for Post Infarct Angina in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries: A MINOCA-BAT Sub Study Rationale and Design"],"prefix":"10.3389","volume":"8","author":[{"given":"Sivabaskari","family":"Pasupathy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertil","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Tavella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna M.","family":"Nordenskj\u00f6ld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Zeitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Arstall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Worthley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Neil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuljit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adil","family":"Rajwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Beltrame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1002\/ccd.26043","article-title":"Incidence and characteristics of patients presenting with acute myocardial infarction and non-obstructive coronary artery disease","volume":"86","author":"Najib","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"B2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.114.011201","article-title":"Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries","volume":"131","author":"Pasupathy","year":"2015","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1161\/CIRCULATIONAHA.117.027666","article-title":"Myocardial infarction with Nonobstructive Coronary Arteries (MINOCA): the past, present, and future management","volume":"135","author":"Pasupathy","year":"2017","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/joim.12857","article-title":"Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries","volume":"285","author":"Eggers","year":"2019","journal-title":"J Intern Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1136\/heartjnl-2018-313665","article-title":"Outcome after myocardial infarction without obstructive coronary artery disease","volume":"105","author":"Williams","year":"2019","journal-title":"Heart"},{"key":"B6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/ehjqcco\/qcv014","article-title":"Angina frequency after acute myocardial infarction in patients without obstructive coronary artery disease","volume":"1","author":"Grodzinsky","year":"2015","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0255462","DOI":"10.1371\/journal.pone.0255462","article-title":"Variability of discharge medical therapy for secondary prevention among patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) in the United States","volume":"16","author":"Smilowitz","year":"2021","journal-title":"PLoS ONE"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e011990","DOI":"10.1161\/JAHA.119.011990","article-title":"Prognosis and predictors of mortality in patients suffering myocardial infarction with non-obstructive coronary arteries","volume":"8","author":"Choo","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijcard.2019.02.036","article-title":"Myocardial infarction with non-obstructive coronary arteries (MINOCA) in Chinese patients: clinical features, treatment and 1year follow-up","volume":"287","author":"Abdu","year":"2019","journal-title":"Int J Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.amjcard.2014.02.015","article-title":"Effects of angiotensin-converting enzyme inhibitors and beta blockers on clinical outcomes in patients with and without coronary artery obstructions at angiography (from a Register-Based Cohort Study on Acute Coronary Syndromes)","volume":"113","author":"Manfrini","year":"2014","journal-title":"Am J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3389\/fphar.2019.01606","article-title":"Secondary prevention medical therapy and outcomes in patients with myocardial infarction with non-obstructive coronary artery disease","volume":"10","author":"Paolisso","year":"2019","journal-title":"Front Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"738","DOI":"10.5603\/CJ.a2020.0130","article-title":"Comparative effect of angiotensin converting enzyme inhibitor versus angiotensin ii type i receptor blocker in acute myocardial infarction with non-obstructive coronary arteries; from the Korea Acute Myocardial Infarction Registry - National Institute of Health","volume":"28","author":"Ahn","year":"2020","journal-title":"Cardiol J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.116.026336","article-title":"Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease","volume":"135","author":"Lindahl","year":"2017","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjcard.2021.01.015","article-title":"Comparison of patients with nonobstructive coronary artery disease with versus without myocardial infarction (from the VA Clinical Assessment Reporting and Tracking [CART] Program)","volume":"146","author":"Kovach","year":"2021","journal-title":"Am J Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/eurheartj\/ehw149","article-title":"ESC working group position paper on myocardial infarction with non-obstructive coronary arteries","volume":"38","author":"Agewall","year":"2017","journal-title":"Eur Heart J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ahj.2020.10.059","article-title":"Randomized evaluation of beta blocker and ACE-inhibitor\/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): rationale and design","volume":"231","author":"Nordenskj\u00f6ld","year":"2021","journal-title":"Am Heart J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1161\/CIRCOUTCOMES.114.000967","article-title":"Development and validation of a short version of the Seattle angina questionnaire","volume":"7","author":"Chan","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11136-004-0614-4","article-title":"Validation of the EQ-5D quality of life instrument in patients after myocardial infarction","volume":"14","author":"Nowels","year":"2005","journal-title":"Qual Life Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the american heart association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/s0735-1097(99)00150-3","article-title":"ACC\/AHA\/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)","volume":"33","author":"Gibbons","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"B23","first-page":"854","article-title":"Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X","volume-title":"Am J Cardiol","author":"Lanza","year":"1999"},{"key":"B24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/01.CIR.65.2.281","article-title":"Exacerbation of vasotonic angina pectoris by propranolol","volume":"65","author":"Robertson","year":"1982","journal-title":"Circulation"},{"key":"B25","first-page":"98","article-title":"Enalapril improves exercise-induced ischaemia in patients with syndrome X","volume":"13","author":"Kaski","year":"1992","journal-title":"Eur Heart J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.717526\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T15:38:05Z","timestamp":1633880285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.717526\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":25,"alternative-id":["10.3389\/fcvm.2021.717526"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.717526","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]},"article-number":"717526"}}